Charles Mathews, Director at AVANIR PHARMACEUTICALS, INC. (AVNR), bought 5,000 shares at $2.69 ($13K) on 2012-03-06, disclosed to the SEC on 2012-03-07.
Open-market purchase of $13k AVNR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.